Insider Ledger

Scilex Holding Co (SCLX) insider buying and SEC filings

Scilex Holding Co · CIK 1820190

Tracked: Forms 3/4/5, 8-K, NT · All filings on sec.gov

Company profile

Exchanges
Nasdaq, Nasdaq
Industry (SIC)
Biological Products, (No Diagnostic Substances)
State of incorporation
DE
Fiscal year end
Dec 31
Former names
Scilex Holding Company/DE; Vickers Vantage Corp. I

Insider activity in the last 12 months

Bought
$0
Insiders who bought
0
Sold (not marked 10b5-1)
$12.8M
Planned sales (10b5-1)
$0

Insider purchases and sales, last 12 months

TradedTypeWhat was filedSource
Apr 17, 2026Other purchaseStephen Hoi Ma (CFO and Director) bought 650,000 Warrant (right to buy) at $0.1500 ($98K), reported as a purchase (code P). New position of 650,000 shares. Not marked as a 10b5-1 plan trade.SEC filing
Filed Apr 20, 2026
Apr 16, 2026Other purchaseHenry Ji (CEO and Director) bought 3,250,000 Warrant (right to buy) at $0.1500 ($488K), reported as a purchase (code P). New position of 3,250,000 shares. Not marked as a 10b5-1 plan trade.SEC filing
Filed Apr 20, 2026
Dec 26–30, 2025SaleHolding Co Scilex (10% owner) sold 20,657,300 shares between Dec 26, 2025 and Dec 30, 2025 at about $0.6200 ($12.8M). Holdings down 8% to 244,445,260 shares. Not marked as a 10b5-1 plan trade.SEC filing
Filed Dec 30, 2025

2 routine transactions (such as grants, option exercises or tax withholding) are not listed.

Cluster buys

No cluster buys in the last 12 months.

Red flags

No red flags in the last 12 months.

Key events

No key events in the last 12 months.

8-K filings, last 12 months

No 8-K filings in the last 12 months.

Red flags are objective triggers only: the item or form filed, never an opinion.

Follow SCLX in the Insider Ledger app

A plain-English brief of insider purchases, 8-Ks and red flags at the companies you pick. No account needed.

Get the app